The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38461065.
- Also identified by DOI 10.1016/j.ejim.2024.02.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Complement System is an evolutionarily conserved component of immunity that plays a key role in host defense against infections and tissue homeostasis. However, the dysfunction of the Complement System can result in tissue damage and inflammation, thereby contributing to the development and progression of various renal diseases, ranging from atypical Hemolytic Uremic Syndrome to glomerulonephritis. Therapeutic interventions targeting the complement system have demonstrated promising results in both preclinical and clinical studies. Currently, several complement inhibitors are being developed for the treatment of complement-mediated renal diseases. This review aims to summarize the most recent insights into complement activation and therapeutic inhibition in renal diseases. Furthermore, it offers potential directions for the future rational use of complement inhibitor drugs in the context of renal diseases.
Medical subject headings
- Complement Activation
- Complement System Proteins
- Disease Progression
- Kidney Diseases
- Complement Inactivating Agents